Attgeno reports first healthy volunteers dosed with Supernitro in Phase I trial

Attgeno AB today announced that the first 8 healthy volunteers have been successfully dosed in a Phase I clinical study with the company’s lead drug candidate, Supernitro. The trial continues according to the clinical protocol and will include up to 48 healthy volunteers. Read more

2021, Mar